Embolization, Inc., a medical device company based in Boulder, Colorado, announced its nitinol-enhanced device (NED) has ...

Thrombolex, Inc., a developer of treatments for arterial and venous thromboembolic diseases, announced the publication of the resu ...

Vivasure Medical announced that it has received European CE Mark approval for an expanded indication for its fully bioresorbable, ...

InspireMD, Inc. announced that the FDA has granted premarket approval of the company’s CGuard Prime carotid stent system in ...

Endovascular Engineering, Inc. (E2) announced the completion of patient enrollment in the pivotal cohort of the ENGULF investigati ...

AngioDynamics, Inc. announced first patient enrollment in the RECOVER-AV clinical trial. The prospective, multicenter, multination ...

Gore & Associates announced that the company’s TAG thoracic branch endoprosthesis (TBE) has received FDA approval for us ...

TRAINING IN ENDOVASCULAR SURGERY DURING THE MECHANICAL THROMBECTOMY (MT) INNOVATION BOOM. I was fortunate to have completed ...

Dr. Fukaya shares tips for a patient-centered venous disease practice, challenges facing the vascular medicine field, where ...

A conversation on data from recent trials, lessons learned for future study, definitions and imaging protocols, how treatment can be refined, and more.

A summary of preclinical evaluation methods for neuroendovascular devices, including in vitro techniques, 3D-printed vascular models, in silico simulations, and in vivo models.

Advantages, disadvantages, what we can learn from the most common neuroprotection strategies, and future directions for the field.